Compound, pharmaceutical composition, use of a compound, method for treating an individual suffering from a pathological condition or disease and combination product
New inhibitors of the p38 mitogen-activated protein kinase having the general formula (I) are disclosed herein, as well as processes for their preparation, pharmaceutical compositions comprising them, and their use in therapy.